$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of multiple mechanisms of action of clofazimine
2026-02-01 22:25:32
Check Details
Clofazimine’s multi-field therapeutic applications
2026-02-01 22:25:32
Check Details
Can I stop taking clofazimine for six months?
2026-02-01 22:25:32
Check Details
Exploring the causes of skin darkening caused by clofazimine
2026-02-01 22:25:32
Check Details
Multiple medical applications of cycloserine
2026-02-01 22:25:32
Check Details
Instructions for using cycloserine, side effects and precautions
2026-02-01 22:25:32
Check Details
Cycloserine Medication Complete Guide
2026-02-01 22:25:32
Check Details
Analysis of the multiple medical effects of cycloserine
2026-02-01 22:25:32
Check Details
Will bleeding occur after taking erlotinib? How long will it take to recover?
2026-02-01 22:25:32
Check Details
The difference between erlotinib and afatinib
2026-02-01 22:25:32
Check Details
Analysis of the main differences between erlotinib and anlotinib
2026-02-01 22:25:32
Check Details
Analysis of duration of side effects of erlotinib
2026-02-01 22:25:32
Check Details
1
2
...
1050
1051
1052
1053
1054
1055
1056
...
10238
10239
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
2
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
3
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
4
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure
5
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
6
Vosoritide Slowing Effect: Not Always Resistance—Check Dose, Adherence, Epiphyses
7
Ramosetron ODT for IBS-D: Gender-Based Dosing and Treatment Review
8
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
9
Acoramidis for ATTR-CM: TTR Stabilizer to Reduce CV Death and Hospitalization
10
Vosoritide Storage and Reconstitution: Refrigerate, 90-Day Room Temp, Use Within 3 Hours
11
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
12
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity